Microbiologics, St. Cloud, Minn, is launching a SARS-CoV-2 control within its Helix Elite line of molecular controls. The product provides quality control measures for the development, verification, and validation of in vitro diagnostics (IVDs) for the novel coronavirus that is the cause of covid-19.

Featuring a large RNA molecule that matches the sequence of the virus N gene (which codes for the nucleocapsid phosphoprotein found in the shell of the virus), the SARS-CoV-2 Helix Elite control works with CDC-specified test components to generate positive PCR signals. 

“With all the unknowns of this new coronavirus strain, third-party IVD controls with the right genomic targets are more critical than ever,” says Marylou Gibson, PhD, chief virologist at Microbiologics. “This new SARS-CoV-2 control comes with the proven quality of the Helix Elite product line to assure labs’ test results.”  

For more information, visit Microbiologics.